Trading practices in domesticated animals allow infectious diseases to spread rapidly and to encounter novel hosts in newly sympatric wildlife^[@R12]^. This "spillover" of infectious disease from domesticated livestock to wildlife populations is one of the main sources of Emerging Infectious Disease (EIDs)^[@R13]^. Small or declining populations are particularly challenged, as the source host may act as a disease reservoir^[@R14]^, giving rise to repeated spillover events and frequent disease outbreaks which, in the worst case, might drive already vulnerable or unmanaged populations to extinction^[@R14]^. Such severe impacts have been well documented over the past decades in vertebrates^[@R10]^, but have largely been overlooked in invertebrates^[@R15]^. Recent years have seen elevated losses in multiple populations of one of the major crop pollinating insects, the honey bee (*Apis mellifera*)^[@R16]^. EIDs have been suggested as key drivers of decline, with deformed wing virus (DWV) (especially in combination with the exotic *Varroa* mite (*Varroa destructor*)) and *Nosema ceranae* (*N. ceranae*) being two likely causes for losses of *Apis*^[@R17]^. As generalist pollinators, honey bees are traded and now distributed almost worldwide for crop pollination and hive products. They share their diverse foraging sites with wild pollinators and thus facilitate interspecific transmission of pathogens, as has been suggested for intraspecific disease transmission from commercial to wild bumble bee populations^[@R18]^. Our focus is on inter-specific transmission, as EIDs in *Apis* are a potential threat to a range of wild pollinators worldwide. Whilst evidence from small scale studies suggests that wild pollinators like *Bombus* spp. may already harbour some honey bee pathogens^[@R7],[@R8],[@R19],[@R20]^, the true infectivity and landscape scale distribution of these highly virulent EIDs in wild pollinator populations remains unknown

To examine the potential for *Apis* pathogens to cross host-genus boundaries, we tested the infectivity of the DWV complex (which includes the very closely related, co-occurring and recombinant *Varroa destructor* virus (VDV)^[@R21],[@R22]^; we will refer to "DWV complex" as "DWV" throughout the text) and *N. ceranae*, in controlled inoculation experiments, to one of the most common *Bombus* species in Great Britain (*B. terrestris*). DWV is infective for *B. terrestris*; we found significantly more DWV infections 21 days after inoculating *B. terrestris* workers versus control (likelihood ratio test comparing the full model to one with only the intercept: X^2^ = 5.73, df = 1, p \< 0.017; [Fig 1](#F1){ref-type="fig"}) and mean survival was reduced by 6 days. As for *Apis,* DWV causes deformed wings in *Bombus* when overtly infected^[@R8]^, resulting in non-viable offspring and reduced longevity ([Fig 1](#F1){ref-type="fig"}). *N. ceranae* is also infective for *B. terrestris*; infections increased in *Bombus* versus control (X^2^ = 17.76, df = 1, p \< 0.001; [Fig 1](#F1){ref-type="fig"}), though overt symptoms were not seen (mean survival increased by 4 days).

Having established both DWV and *N. ceranae* as infective for *B. terrestris*, we conducted a structured survey across 26 sites in GB and the Isle of Man, collecting 10 *Apis* samples, and 20 *Bombus* samples per site to assess EID prevalence (for details on the species identity across sites, see [Extended Data Fig. 1](#SD1){ref-type="supplementary-material"}). We analysed a total of 745 bees from 26 sites for DWV presence, DWV infection (replicating DWV) and *N. ceranae* presence. DWV was present in 20% (95% confidence interval (CI) 17-23%) of all samples; 36% (95% CI: 30-43%) of *Apis* and 11% (95% CI: 9-15%) of *Bombus*. Of the *Apis* harbouring DWV, 88% (95% CI: 70-98%) of the samples tested had actively replicating virus, whilst 38% (95% CI: 25-53%) of *Bombus* harbouring DWV had replicating virus (see [Extended Data Fig. 2](#SD2){ref-type="supplementary-material"} and [Extended Data Table 1](#SD4){ref-type="supplementary-material"}). *N. ceranae* was less frequent, being detected in 7% (95% CI: 6-10%) of all samples; 9% (95% CI: 6-13%) of *Apis* samples and 7% (95% CI: 5-9%) of *Bombus* samples.

We estimated the GB-wide prevalence of the two pathogens in *Apis* and *Bombus* spp. based on our field survey data ([Fig. 2](#F2){ref-type="fig"}). We found no evidence for spatial clustering of DWV presence in *Bombus* (Moran's I = 0.023, p \> 0.211) or either of the pathogens in *Apis* (DWV presence: Moran's I = 0.03, p \> 0.186; *Nosema*: Moran's I = −0.061, p \> 0.649). There was, however, weak clustering of DWV infection in *Bombus* (Moran's I = 0.061, p \< 0.044) and very strong clustering of *N. ceranae* in *Bombus* (Moran's I = 0.25, p \< 0.001), indicating disease hotspots for DWV in *Bombus* in the south west and east of GB and for *N. ceranae* in *Bombus* in the south east of GB ([Fig. 2](#F2){ref-type="fig"}). Because prevalence was lower in *Bombus* than *Apis*, we modelled pathogen prevalence in *Bombus* as dependent on pathogen prevalence in *Apis, Bombus* to *Apis* density, and *Apis* abundance, including biologically relevant interactions whilst controlling for latitude, longitude, and sunlight hours, and adding collection site and species identity as random factors. Our full model for DWV presence was significantly better than the null model without any of the test predictors and their interactions included (likelihood ratio test: X^2^ = 19.03, df = 5, p \< 0.002). After removal of the non-significant interactions (GLMM: *Bombus* to *Apis* density X DWV presence in *Apis*: estimate ± SE = −0.105 ± 1.376, p = 0.939; *Apis* abundance X DWV presence in *Apis*: 0.425 ± 1.309, p=0.745), it is clear that prevalence of DWV in *Apis* has a strong positive effect on DWV prevalence in *Bombus* (GLMM: 2.718 ± 0.921, z = 2.951, p \< 0.004) ([Fig. 2](#F2){ref-type="fig"}, [Extended Data Fig. 3](#SD3){ref-type="supplementary-material"}), while none of the other predictors played a role (GLMM: *Bombus* to *Apis* density: 0.315 ± 0.387, z = 0.814, p \< 0.416; *Apis* abundance: −0.085 ± 0.364, z = −0.232, p \< 0.816). In the case of *N. ceranae*, our full model was significantly better than the null model (X^2^ = 15.8, df = 5, p \< 0.008). Specifically there was an effect of *Nosema* prevalence in *Apis* on *Nosema* prevalence in *Bombus* and this varied with *Apis* abundance (interaction between *Nosema* prevalence in *Apis* and *Apis* abundance: X^2^ = 7.835, df = 2, p \< 0.02), while *Bombus* to *Apis* density did not explain *Nosema* prevalence in *Bombus* (GLMM: 8.386 ± 6.793, z = 1.235, p = 0.217) ([Fig. 2](#F2){ref-type="fig"}, [Extended Data Fig. 3](#SD3){ref-type="supplementary-material"}).

The prevalence data implied local transmission of DWV between *Apis* and *Bombus*. To test this, we sequenced up to 5 isolates per DWV infected *Bombus* sample from 5 sites matched by up to 5 isolates of sympatric DWV infected *Apis* samples. If a pathogen is transmitted between these two hosts, we would expect *Apis* and *Bombus* to share the same DWV strain variants within a site. Marginal log likelihoods estimated by stepping stone sampling^[@R23]^ decisively support clades constrained by site as opposed to host, indicating pathogen transmission within site ([Fig. 3](#F3){ref-type="fig"}, [Extended Data Table 2](#SD5){ref-type="supplementary-material"}).

Our results provide evidence for an emerging pathogen problem in wild pollinators that may be driven by *Apis.* Our data cannot demonstrate directionality in the interspecific transmission of DWV. However, the high prevalence of DWV in honey bees, which is a consequence of the exotic vector *Varroa destructor*^[@R24]^, is consistent with their acting as the major source of infection for the pollinator community. Similar results have been found for intraspecific transmission of *Bombus*-specific pathogens from high prevalence commercial *Bombus* colonies to low prevalence wild *Bombus* populations^[@R18]^. Our field estimates of prevalence are conservative for DWV, as highly infected individuals have deformed wings, are incapable of flight, and thus would not be captured by our sampling protocol. Consequently, DWV prevalence and, as a result, impact are likely to be higher in managed and wild populations than our data suggest. Interestingly, *N. ceranae* prevalence in *Bombus* depends positively on *Apis* abundance, but only when *N. ceranae* prevalence in *Apis* is low, suggesting a possible environmental saturation effect of *N. ceranae* spores. In contrast to the low impact of *N. ceranae* on the survival of *B. terrestris* in our study, Graystock et al.^[@R25]^ found very high virulence. This might be explained by our use of young bees vs Graystock et al.'s^[@R25]^ non-age-controlled design, indicating age dependent differential susceptibility in *B. terrestris,* as has been shown to be the case in honey bees^[@R26]^.

Ongoing spillover of EIDs could represent a major cause of mortality of wild pollinators wherever managed bees are maintained. While our data are only drawn from GB, the prerequisites for honey bees to be a source or reservoir for these EIDs -- high colony densities and high parasite loads -- are present at a global scale. In addition, global trade in both honey bees and commercial *Bombus* may exacerbate this impact^[@R6],[@R27]^. Reducing the pathogen burden in managed honey bees so as to reduce the risk of transmission to wild pollinators is not straightforward. Tighter control of importation and hygiene levels of transported colonies could be imposed with regulation, but policies developed in this direction must learn from the past; such regulation is difficult to implement and hard to evaluate^[@R9],[@R28]^. Clearly, it is essential to ensure that those managing bees (including commercial producers, growers and beekeepers) have access to the methods and skills to monitor, manage and control EIDs for the benefit of their managed colonies, and the wider pollinator community. A consensus on the threat of EIDs for wild pollinators can only be reached with greater knowledge of their epidemiology, global extent and impact, and it will be crucial to involve key stakeholders (e.g. the beekeeping community, *Bombus* exporters) in any decision process, as any progress made will largely be driven by their actions.

Methods {#S5}
=======

*Bombus* inoculation experiment {#S6}
-------------------------------

Each of the 7 experimental *Bombus terrestris* colonies (Biobest) was tested for presence of the two treatment pathogens DWV and *N. ceranae.* Daily, callows (newly emerged workers) were removed from the colony, assigned sequentially to random treatment blocks and housed individually in small Perspex boxes on an *ad libitum* diet of 50% sucrose solution and artificial pollen (Nektapoll), as natural pollen has been shown to contain viable *N. ceranae* spores and DWV virions ^[@R19],[@R37]^. Two day old bumble bee workers were individually inoculated with a treatment dependent inoculum in 10 μl sucrose. Crude hindgut extracts of 5 *Apis* workers propagating *N. ceranae* were purified by the triangulation method^[@R38]^ with slight adaptations.

We used small cages with 30 *N. ceranae* infected honey bees to propagate *N. ceranae* spores for the inoculum. Every second day we collected 5 honey bees from these cages, and removed and ground the hindguts. The resulting extract was filtered through cotton and washed with 0.9% insect ringer (Sigma Aldrich). We triangulated extracts using Eppendorf tubes and spin speeds of 0.5g for 3 minutes, purifying *N. ceranae* spores over 7 tubes. Spore numbers were quantified in a Neubauer counting chamber. In parallel, we extracted and purified *N. ceranae* free bees to use for control inoculations.

DWV virus inoculum was prepared according to Bailey & Ball^[@R39]^ with modifications. Honeybees with DWV symptoms (crippled wings and body deformities) were crushed in 0.5M potassium phosphate buffer (pH 8.0), filtered and clarified by slow speed centrifugation (8000*g* for 10 minutes) before being diluted and injected (1μl) into white-eyed pupae for bulk propagation of virus. After 5 days, up to 100 pupae were harvested, and after a further screen by qRT-PCR, virus was purified as follows. Virus extraction buffer consisted of 0.5M potassium phosphate pH 8.0, 0.2% DEICA, 10% diethyl ether. Purification consisted of two slow speed clarifications (8000*g* for 10 minutes), one high speed clarification (75000*g* for 3 hours) followed by re-suspension in 0.5M potassium phosphate buffer (ph8.0) and a final slow speed clarification. Virus preparations were aliquoted and stored at −80°C until use in inoculation experiments.

The purified virus was checked by quantitative Reverse Transcription (qRT) PCR for the presence of DWV and the absence of other common honey bee RNA viruses: BQCV, IAPV, SBV, CBPV, ABPV, and SBPV by PCR.

A duplicate dilution series of external DNA standards covering 10^2^ to 10^8^ molecules (reaction efficiencies: 90-110%, r^2^: 0.95-0.99) were included in qRT-PCR runs to quantify DWV genome equivalents present in the inoculum. For absolute quantification of virus dose, an external DNA standard was generated by amplifying a genomic fragment of 241bp using the primers F8668*std* (5′-GAT GGG TTT GAT TCG ATA TCT TGG-3′) and B8757*std* (5′-GGC AAA CAA GTA TCT TTC AAA CAA TC-3′) via RT-PCR that contained the 136bp fragment amplified by the DWV-specific qRT-PCR primers F8668/B8757^[@R40]^.

Shortly before administering, inocula were prepared to a total concentration of 10^5^ spores/bee in 10 μl (10^4^ spores/μl sucrose solution). Inocula were administered individually in a small Petri dish after 30-60 minutes starvation. Only workers ingesting the full 10 μl within 1h were used in the experiment.

Sampling scheme {#S7}
---------------

The mainland sampling sites were chosen across Great Britain along a north-south transect (12 sampling points with fixed latitude, but free in longitude) and across two east-west transects (12 sampling points with fixed longitude, but free within a narrow latitudinal corridor). Each of the mainland sites were at least 30 km apart (mean ± SD of nearest neighbour = 69.21 ± 26.39). The island sites were chosen deliberately to gain background data for both *Apis* and *Bombus* disease prevalence in the absence of *Varroa*, the main transmission route for DWV in *Apis*. At each sampling site we collected approximately 30 workers for each of the following species: *Apis mellifera, Bombus terrestris* (verified by RFLP-analysis^[@R29]^), and the next most common bumble bee on site. We collected free flying bees from flowers rather than bees from colonies as this is the most likely point of contact in the field. By collecting from flowers we lowered the likelihood of collecting bumblebees from different colonies. While we ran the risk of collecting multiple honeybees from the same hive, this nevertheless represents the potential force of infection for both genera in the field.

Each collection took place along a continuous transect, where maximally ten bees per ten metre stretch were collected before moving on to the next ten metre stretch. At each site, the collection area covered at least 1000 m^2^ (e.g., 10 × 100m, 20 × 50m). Each sampling point was within one of the following landcover types: urban areas (gardens and parks), farmland (hedgerows, border strips, crops, and wildflower meadows), coastal cliffs, sand dunes and heather moorland.

If possible, we collected all bees within a single day. In the case of adverse weather, we returned as soon as possible to finish the collection at the exact same site. To estimate *Apis* and *Bombus* densities at each site we timed the collection effort simultaneously. Time taken to collect 20 *Bombus* workers (of any *Bombus* species) and 20 *Api*s workers was recorded, respectively. Timed collecting efforts took place on a single day only.

Samples collected were put in sampling tubes, transferred straight onto ice, then freeze-killed at −20°C and transferred to −80°C as soon as possible thereafter to ensure optimal RNA (DWV) preservation.

RNA work {#S8}
--------

RNA extraction followed the standard RNeasy plant mini kit (Qiagen) protocol with the final elutate (in RNase free ddH2O) of 30 μl being run over the column twice (for optimal RNA concentration). For reverse transcription of RNA to cDNA we followed the standard protocol of the Nanoscript Kit (Primerdesign). Our priming was target specific in separate reactions for *N. ceranae* (primer pair *N. ceranae*^[@R41]^), DWV (primer pair F15/B23^[@R42]^) and a housekeeping gene (primer pair ACTB^[@R43]^) as a positive control for RNA extraction efficiency. Bees were transferred to liquid N~2~ prior to dissection. Each bee's abdomen was cut with a sterile scalpel dorsoventrally along the sagittal plane. One half was submerged in RLT buffer (Qiagen) for RNA extraction, and the second half was archived at −80C. Tissue disruption and homogenisation of individual half-abdomens was performed on a tissue lyser II (Qiagen) at 30Hz for 2 minutes followed by 20Hz for 2 minutes. RNA quality and quantity were checked on a Spectrometer (Nanodrop, Thermo Scientific). cDNA preparation was conducted at 65°C for 5 minutes for the initial priming immediately before the addition of the reverse transcriptase. For the extension, samples were incubated at 25°C for 5 minutes followed by 55 °C for 20 minutes and then heat inactivated for 15 minutes at 75°C. cDNA was used as template in a standard PCR with 57°C, 54°C, and 57°C annealing temperatures, respectively. Results were visualized on a 2% agarose gel with EtBr under UV light. Agarose gels were scored without knowledge of sample ID. To verify the specificity of the amplicon, one purified PCR product taken from *Apis* and one taken from *B. lapidarius* were sequenced (Macrogen Inc.).

Detection of negative strand DWV {#S9}
--------------------------------

Detection of pathogens in pollinators in the field does not provide proof of infection, as pathogens are likely being ingested on shared, contaminated food resources and therefore are inevitably present in the gut-lumen as passive contaminants without necessarily infecting the host. To minimize these cases, we tested all our DWV positive *Bombus* samples and a subset of DWV positive *Apis* samples for virus replication, a strong indicator for infection^[@R44]^. DWV is a positive strand virus whose negative strand is only present in a host once the virus is actively replicating^[@R39]^. Reverse transcription was conducted using a tagged primer tagB23^[@R45]^ for the initial priming to target exclusively the negative strand. The resulting cDNA was used in a PCR with the tag sequence and F15 as primers^[@R30],[@R45]^. We tested all *Bombus* samples that were positive for DWV presence and, where possible, 2 DWV-positive *Apis* samples from each site where we found DWV in *Bombus*.

Sequencing {#S10}
----------

DWV sequence diversity was analysed by sequencing up to 5 independent clones per DWV negative-strand infected *Bombus* sample from 5 sites (H, L, Q, R, X; chosen for their high DWV infected prevalence in *Bombus*) and 5 clones of DWV infected *Apis* samples from the same sites (we checked extra *Apis* samples for DWV infection if necessary to match *Bombus* DWV infections). All *Bombus* samples were *B. lapidarius* with the exception of one sample from site L (clone05), which was *B. pascuorum* (this sample is not included in any of the other analyses, but revealed a DWV infection in an initial screening and was hence included in the virus variant analysis). We sequenced a region of the DWV genome: the RNA-dependent RNA polymerase (RdRp) gene (F15/B23 primer pair^[@R42]^ used throughout the study). RdRp is thought to be a conserved region of the virus genome where non-synonymous substitutions may have significant implications for the epidemiology of the virus ^[@R24]^. RT-PCRs and PCR were run as described before. DWV PCR products were verified by gel electrophoresis as described above; if a clear, clean single band was visible, we proceeded directly to the cloning protocol. If not, we purified products from the agarose gel following a standard protocol (Qiaquick Gel Extraction Kit, Qiagen) and used the purified fragment in an additional PCR. PCR products were cloned using the Invitrogen TA cloning kit (Invitrogen), according to the manufacturer's instructions. Plasmid DNA was isolated using the Spin Miniprep kit (Qiagen) and the successful insertion of target sequence was tested by restriction analysis (digested with EcoR I). Up to 5 clones per sample were sequenced in forward and reverse orientation (Source BioSciences, Cambridge).

Analysis of DWV sequences {#S11}
-------------------------

The 75 *Apis* and *Bombus* clones from sites H, L, Q, R and X were supplemented with DWV and VDV reference RdRp sequences (accession nos. NC004830 and NC006494 respectively), resulting in a final alignment of 420bp from 77 sequences. Forward and reverse sequences of each clone were assembled and the consensus sequence was used for further analysis. Sequences were aligned using Geneious (R 6.1.6) with standard settings. Ends were trimmed by hand. For the tree building we conducted two independent (MC)^[@R3]^ algorithms running for 2 million generations, each with four chains (3 hot, 1 cold), sampling one tree in 1000, under the GTR**+**Ґ (nst **=** 6) substitution model. Gene trees were estimated using PhyML v.3.0^[@R46]^ maximum-likelihood (ML) bootstrapping (500 replicates) and MrBayes v3.1.2^[@R47]^, under a GTR model of sequence evolution and a gamma (Ґ) model, using 4 categories to accommodate rate variation across sites. Burn-in cutoffs were inspected manually for each parameter file in Tracer v1.4^[@R48]^. Inspection of the standard deviation of split frequencies confirmed that runs had converged (0.0093). To test alternative *a priori* hypotheses of virus diversification, for each virus (DWV and VDV) we constrained clades according to site (H, L, Q, R and X) or host genus (*Apis* and *Bombus*), and performed stepping stone sampling^[@R23]^ as implemented in MrBayes v3.1.2 to accurately estimate marginal log likelihoods. MCMC sampling was conducted for 50 steps of 39000 generations each, with the first 9000 generations of every step discarded as burn-in. The model with the highest likelihood score was used as the null hypothesis. We compared Bayes Factors (BF) for both models and used a threshold of 2 ln (BF) \> 10 as decisive support for the null against the alternative hypothesis^[@R49]^ ([Supplementary Table 2](#SD5){ref-type="supplementary-material"}). We repeated stepping stone sampling to confirm run stability (data not shown).

Statistics {#S12}
----------

Mean survival of control treatments, free of the two test pathogens, was 14.2 ± 4.2 (mean ± sd) days, while DWV treated bees survived for 8.1 ± 5.8 (mean ± sd) days. To assess the effect of infection on survival we fitted a Cox mixed effects model with treatment as a fixed factor and colony origin as random factor and compared it to the null model ^[@R50]^(R library coxme, version 2.2-3, function coxme). The model was fitted with the penalized partial likelihood (PPL) and showed a significant negative impact of infection on longevity (X^2^ = 11.93, df = 4.17; p \< 0.021).

*N. ceranae* treated bees survived for 18 ± 1 (mean ± sd) days. A model with treatment as fixed factor and colony origin as random factor showed no improvement over the null model (PPL: X^2^ = 0.12, df = 1; p \> 0.735).

True prevalences with 95% confidence intervals were computed to correct for varying sample sizes (due to the different species of bumble bee at the sampling sites) and test sensitivity was set to a conservative 95% ^[@R51]^. Confidence interval estimates are based on Blaker's (2000) method for exact two sided confidence intervals ^[@R52]^ for each sampling site and for each species sampled ^[@R31]^(R library epiR, version 0.9-45, function epi.prev).

To investigate our spatially distributed dataset we undertook an exploratory data analysis (EDA)^[@R53]^ in which we calculated a prevalence surface for each of our parasites using Gaussian kernel estimators with an adaptive bandwidth of equal number of observations. This is a variant of the nearest neighbour technique, with bandwidth size being determined by a minimum number of observations in the neighbourhood (set to 3 times the maximum observations per site)^[@R32]^ (R library prevR, version 2.1, function kde). Estimated surfaces were used for visual inspection only ([Fig. 2](#F2){ref-type="fig"}); all the remaining analyses are based on the raw data only.

To investigate spatial structure and disease hotspots we used spatial autocorrelation statistics of the true prevalence of each of the pathogens in the different host genera from the 26 collection sites. To identify whether or not the pathogens we found were spatially clustered, we computed the spatial autocorrelation coefficient Moran's I^[@R54]^ with an inverse spatial distance weights matrix, as implemented in Gittleman and Kot ^[@R55]^ (R library ape, version 3.0-7, function Moran.I). Moran's I is a weighted measure describing the relationship of the prevalence values associated with spatial points. The coefficient ranges from −1 (perfect dispersion) through 0 (no spatial autocorrelation (random distribution)) to 1 (perfect clustering).

To investigate whether pathogen prevalence (*Nosema* and DWV were tested in separate models) in *Apis, Bombus* to *Apis* relative density, or *Apis* absolute abundance had an effect on pathogen prevalence in *Bombus*, we ran a Generalized Linear Mixed Model (GLMM) ^[@R34]^ with binomial error structure and logit link function using the function lmer of the R package lme4^[@R35]^. Latitude, longitude, sunlight hours (a proxy for favourable foraging weather that would enable disease transmission; calculated cumulatively from March until the month of collection \[data were collected from the MET office webpage: <http://www.metoffice.gov.uk/climate/uk/anomacts/>, averaging over area sunlight hour ranges\]) and landcover type were included in the model as fixed control effects (present in the full as well as the null model) while site and species were included in the model as random effects (present in the full as well as the null model). Before running the model we inspected all predictors for their distribution, as a consequence of which we log transformed "*Bombus* to *Apis* density" and "*Apis* abundance" to provide more symmetrical distributions. Thereafter we z-transformed all quantitative predictors to a mean of zero and a standard deviation of one to derive more comparable estimates and to aid interpretation of interactions^[@R56]^. Since changes in "*Bombus* to *Apis* density" and "*Apis* abundance" could lead to changes in pathogen prevalence in *Bombus* because of a change in pathogen prevalence in *Apis*, we included the interactions between "*Bombus* to *Apis* density" and pathogen prevalence in *Apis,* and "*Apis* abundance" and pathogen prevalence in *Apis*. To test the overall effect of our three test predictors, we compared the full model with a reduced model (null model) using a likelihood ratio test comprising latitude, longitude, sunlight hours and landcover type with the same random effects structure. Model stability was assessed by excluding data points one by one and comparing the estimates derived from these reduced models with estimates from the full model (revealing a stable model). Site G had to be excluded from this analysis as no *Apis* samples were found on site.

We fitted linear models to assess the relationships of parasite prevalence among *Apis* and *Bombus.*

We investigated the effect of pathogen treatment on disease status of an individual with a Generalized Linear Mixed Model (GLMM) ^[@R34]^) with binomial error structure and logit link function using the function lmer of the R package lme4^[@R35]^. Colony of origin was entered into the model as a random effect. As described before, we checked model stability (the model with interaction terms included was unstable; however it stabilised once the non-significant interaction terms were removed), before testing the full model against the null model using a likelihood ratio test. All analyses were run in R^[@R36]^.

Supplementary Material {#SM}
======================

###### Species and site distribution

Distribution of sampling sites across Great Britain and the Isle of Man. The most common *Bombus* species on site is represented by coloured letters while the 2nd most common *Bombus* species is represented by differently coloured dots. Total sample sizes for each site are given in the table.

###### Prevalence per site and species

Pathogen prevalence in *Bombus* spp. in percent per site (a. for DWV; b. for *N. ceranae*) and per species (c. for DWV; d. for *N. ceranae*). Bars indicate 95% confidence intervals. Note different scales

###### Prevalence raw data

The linear models shown only illustrate the relationships but do not drive the conclusions in the main text. a) DWV presence in *Apis* and *Bombus* (adj R^2^ = 0.34, p \< 0.001); b) DWV replicating in *Bombus* and DWV presence in *Bombus* (adj R^2^ = 0.46, p \< 0.001); c) *N. ceranae* presence in *Apis* and *Bombus* (adj R^2^ = −0.04, p \> 0.728). The line shows the best fit and the dark grey region shows 95%CI of fit.

###### Pathogen prevalence per species

Pathogen prevalence is given in percent with 95% confidence intervals (% prevalence \[95% CI\]). Sample numbers (N) are shown in brackets.

Footnote to Extended Data Table 1: \* out of the 31 DWV present *Apis* samples tested

###### Alternative hypotheses for the diversification of DWV and VDV viruses in UK pollinators
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![Infectivity\
Prevalence of infections in treated *Bombus terrestris* workers 21 days after inoculation (in percent). Bars indicate 95% confidence intervals. Colours indicate treatment, with *Nosema* treated samples in green and DWV treated samples in black. Sample sizes are given inside the mean data point. The survival graph over the 21 day test period shows uninfected control treatments in grey compared to infected DWV treatments in blue (Cox mixed effects model fitted with penalized partial likelihood: X2 = 11.93, df = 4.17; p \< 0.021, see [Supplementary Information](#SD1){ref-type="supplementary-material"}).](emss-56161-f0001){#F1}

![Prevalence\
Estimated pathogen prevalence in *Apis* and *Bombus* across Great Britain and the Isle of Man. Colour gradient (based on Gaussian kernel estimators with an adaptive bandwidth of equal number of observations over 26 sites, see Methods) corresponds to percent prevalence (note different scales). DWV prevalence is displayed in blue and *Nosema* prevalence in green.](emss-56161-f0002){#F2}

![Viral strain relations\
RNA-dependent RNA polymerase (RdRp) partial gene phylogeny of pollinator viruses (main text). Gene trees were estimated using PhyML v.3.0 maximum-likelihood (ML) bootstrapping (500 replicates) and MrBayes v3.1.2 (see Methods). Coloured boxes correspond to sites H, L, Q, R and X (as shown on the map) while text colours correspond to host (Red: *Bombus*; Black: *Apis*). Symbols represent node support values: posterior probability (left), bootstrap support (right). Filled circle: \>90%, Target symbol: \>70%, Empty circle: \>50%. Branches (//) one third of true length.](emss-56161-f0003){#F3}
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